Home›People›Lyn Baranowski
LB

Lyn Baranowski

Chief Executive Officer and director at Avalyn Pharma.

ExecutiveDirectorPublic company
Updated Oct 27, 2026·Latest SEC filing May 1, 2026·Suggest an edit

About Lyn Baranowski

Lyn Baranowski is a chief executive officer and director at Avalyn Pharma.

Lyn Baranowski reports to the SEC as a director or officer of 2 public companies, including Rani Therapeutics (RANI).

Lyn Baranowski first appears on SEC filings in 2021.

Experience

This experience comes from SEC filings. The years are when the filings name Lyn Baranowski in the role, so the role may have started earlier or lasted longer.

Avalyn Pharma Inc.
Chief Executive Officer and director
2023 – 2026 · Public company (AVLN)
Rani Therapeutics Holdings, Inc.
Director
2021 – 2022 · Public company (RANI)

Key Colleagues at Startups

The people Lyn Baranowski works with at each company, as listed on that company's latest Form D.

Avalyn Pharma Inc. · Form D, Oct 10, 2023
TA
Tiba Aynechi
Director
KP
Ketan Patel
Director
PM
Peter Moldt
Director
ND
CL
JL
JC
Jill Carroll
Director

Sources

  1. SECAvalyn Pharma Inc. Form D, filed Oct 10, 2023
  2. SECForms 3, 4 and 5 filed by Lyn Baranowski (SEC filer 1893640)